Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Large Decline in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 43,600 shares, a decline of 62.4% from the December 15th total of 116,100 shares. Currently, 3.2% of the company’s stock are sold short. Based on an average trading volume of 1,160,000 shares, the days-to-cover ratio is presently 0.0 days.

Arcadia Biosciences Trading Up 1.0 %

Shares of Arcadia Biosciences stock traded up $0.05 during trading on Tuesday, reaching $4.90. The company’s stock had a trading volume of 5,647 shares, compared to its average volume of 25,206. The stock has a 50-day moving average price of $4.72 and a two-hundred day moving average price of $3.63. The stock has a market capitalization of $6.69 million, a P/E ratio of -1.14 and a beta of 0.90. Arcadia Biosciences has a one year low of $1.85 and a one year high of $10.31.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Arcadia Biosciences in a report on Friday. They set a “sell” rating on the stock.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.